Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1373233-17-0

N-BOC-3-(BenzyloxyMethyl)azetidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1373233-17-0

Post Buying Request

1373233-17-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1373233-17-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1373233-17-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,3,2,3 and 3 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1373233-17:
(9*1)+(8*3)+(7*7)+(6*3)+(5*2)+(4*3)+(3*3)+(2*1)+(1*7)=140
140 % 10 = 0
So 1373233-17-0 is a valid CAS Registry Number.

1373233-17-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 3-(phenylmethoxymethyl)azetidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names N-BOC-3-(Benzyloxymethyl)azetidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1373233-17-0 SDS

1373233-17-0Downstream Products

1373233-17-0Relevant articles and documents

TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE

-

Page/Page column 290-291, (2021/09/04)

This disclosure relates to bivalent compounds (e.g., bi-functional small molecule compounds), compositions comprising one or more of the bivalent compounds, and to methods of use the bivalent compounds for the treatment of certain disease in a subject in need thereof. The disclosure also relates to methods for identifying such bivalent compounds.

TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE

-

Page/Page column 201-202, (2020/03/15)

Bivalent compounds, compositions comprising one or more of the bivalent compounds, and methods of use the bivalent compounds for the treatment of certain disease in a subject in need thereof are provided. Methods for identifying such bivalent compounds are provided, either.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1373233-17-0